Protein Engineering for Therapeutics, Part B, 1st Edition,K. Dane Wittrup,Gregory L. Verdine,ISBN9780123969620
Add to Wish List
 
 
 
Multi-Volume: Methods in Enzymology

Volume 503: Protein Engineering for Therapeutics, Part B, 1st Edition

Print Book

Editor(s) : Wittrup  &   Verdine  

Release Date:

Imprint: Academic Press

ISBN: 9780123969620

Pages: 392

Dimensions: 229 X 152

This volume of Methods in Enzymology is the companion to volume 502 and looks at Protein Engineering for Therapeutics.

Buy print & eBook together
and save 40%

USD 199.00
Print Book

+

USD 193.00
eBook

USD 392.00Normal price

USD 235.20Bundle price

Add to Cart

Print Book Estimated Delivery Time

Hardcover

USD 199.00

In Stock

eBook eBook Overview

USD 193.00

ePUB format

PDF format

Add to Cart

Buy Print & eBook both and save 40%
View Bundle Price

 
 

Key Features

  • Chapters provide an invaluable resource for academics, researchers and students alike
  • Iinternational board of authors
  • This volume is split into sections that cover subjects such as peptides, and scaffolds
  • Description

    This volume of Methods in Enzymology looks at Protein Engineering for Therapeutics. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume is split into sections that cover subjects such as Peptides, and Scaffolds

    K. Dane Wittrup

    Gregory L. Verdine

    Protein Engineering for Therapeutics, Part B, 1st Edition

    Part III: Peptides

    1. Stapled Peptides for Intracellular Drug Targets
    2. Gregory L. Verdine and Gerard J. Hilinski

    3. Mapping of vascular zip codes by phage display
    4. Tambet Teesalu, Kazuki N. Sugahara & Erkki Ruoslahti

    5. Engineering cyclic peptide toxins
    6. Richard J. Clark and David J. Craik

    7. Peptide Discovery using Bacterial Display and Flow Cytometry
    8. Jennifer A. Getz, Tobias D. Schoep, Patrick S. Daugherty

      Part V: Scaffolds

    9. Designed Ankyrin Repeat Proteins (DARPins): From research to therapy
    10. Rastislav Tamaskovic, Manuel Simon, Nikolas Stefan, Martin Schwill and Andreas Plückthun

    11. Target-binding proteins based on the tenth human fibronectin type III domain (10Fn3)
    12. Shohei Koide, Akiko Koide, and Daša Lipovšek

    13. Anticalins: small engineered binding proteins based on the lipocalin scaffold
    14. Michaela Gebauer and Arne Skerra

    15. T Cell Receptor Engineering
    16. Jennifer D. Stone, Adam S. Chervin, David H. Aggen, David M. Kranz

    17. Engineering Knottins as Novel Binding Agents
    18. Sarah J. Moore and Jennifer R. Cochran

      Part VI: Pharmacokinetics

    19. Practical Theoretic Guidance for the Design of Tumor Targeting Agents
    20. K. Dane Wittrup, Greg M. Thurber, Michael M. Schmidt, John J. Rhoden

    21. Re-Engineering Biopharmaceuticals for Targeted Delivery Across the Blood-Brain Barrier
    22. William M. Pardridge and Ruben J. Boado

    23. Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells

    David B. Thompson, James J. Cronican, and David R. Liu

    »
    Protein Engineering for Therapeutics, Part B